Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02346591 · ClinicalTrials.gov registry record · Phase 2
Mobile-Web Emotion Self-management Tool
A Phase 2 study, sponsored by Oregon Center for Applied Science.
- Completed
- Registry status
- Phase 2
- Development phase
- 298
- Enrollment target
NCT02346591: Completed Phase 2 study, sponsored by Oregon Center for Applied Science.
NCT02346591 is a Phase 2 study that has completed, run by Oregon Center for Applied Science. The registered enrollment target is 298 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (124% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02346591, a Phase 2 study, has completed, sponsored by Oregon Center for Applied Science.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 298 participants
- Enrollment target
Study Summary
The investigators developed a responsive mobile-web app, "Jauntly," which was designed to take advantage of the known connections between positive emotions, stress reduction and stress resilience. The app's goal was to lead users through research-proven positive emotion-enhancing exercises and relevant educational materials. Intervention activities covered five well-being-generating content areas: 1) promoting the experience and recognition of gratitude; 2) encouraging positive social relationships and feelings of social support; 3) improving stress resilience via mindfulness and other relaxation-focused activities; 4) focusing and capitalizing on individual strengths (as opposed to limitations and weaknesses); and 5) general positive mood inducing activities. Program content was adapted from a variety of stress-relevant research areas including health psychology/psychosomatic medicine, social/personality psychology, positive psychology, and clinical psychology.
Primary Outcome
The 10-item Perceived Stress Scale (PSS) assessed perceptions of feeling like you can not cope with things in your life and feelings of "stress" and nervousness on a scale of 1 (Never) to 5 (Very Often). The PSS is the most widely used self-report stress scale available, and has been shown to predict many important well-being outcomes.
Interventions
- BEHAVIORAL Jauntly
- BEHAVIORAL Online stress management information
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 298 participants |
| Start Date | 2013-02 |
| Est. Completion | 2013-11 |
| Phase | Phase 2 |
What the finished NCT02346591 record still lists
NCT02346591 is an interventional study that assigns participants to a tested intervention. The registered 298 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (124% higher).
The record links to 0 conditions, and to 2 interventions - of which Jauntly is the first listed.
NCT02346591 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02346591 about?
NCT02346591 is a clinical study titled "Mobile-Web Emotion Self-management Tool". The investigators developed a responsive mobile-web app, "Jauntly," which was designed to take advantage of the known connections between positive emotions, stress reduction and stress resilience. The app's goal was to lead users through research-proven positive emotion-enhancing exercises and relev...
What is the current status of trial NCT02346591?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 298 participants. The study started on 2013-02. Estimated completion is 2013-11.
What interventions are being tested in trial NCT02346591?
The interventions under investigation include: Jauntly (BEHAVIORAL), Online stress management information (BEHAVIORAL).
Who is sponsoring clinical trial NCT02346591?
This trial is sponsored by Oregon Center for Applied Science, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02346591's enrollment target sits among peer trials
298 188th of 2000 higher than 1,813 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06305624 · 298 participants · NA
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
- NCT06754215 · 298 participants · NA
Smoking Cessation Intervention Development for Homeless Youth
- NCT06780111 · 298 participants · Phase 1
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
- NCT07209358 · 298 participants · NA
EDX110 Randomized Control Trial for Treatment of DFUs
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia